Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Bruning

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Neurology|July 13, 2000
Response of leptomeningeal metastases from breast cancer to hormonal therapyW Boogerd, L D Dorresteijn, J J van Der Sande, et al.
Cancer|March 26, 1999
Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinomaS B Schagen, F S van Dam, M J Muller, et al.
Journal of Chromatography|July 13, 1990
High-performance liquid chromatographic method for the analysis of 10-ethyl-10-deaza-aminopterin and metabolites in plasmaO van Tellingen, J H Beijnen, H R van der Woude, et al.
International Journal of Epidemiology|February 8, 2000
Body fat distribution and obesity in pre- and postmenopausal breast cancerE Sonnenschein, P Toniolo, M B Terry, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
Pamidronate infusions as single-agent therapy for bone metastases: a phase II trial in patients with breast cancerC T Tyrrell, P F Bruning, F May-Levin, et al.
International Journal of Obesity|January 1, 1991
Abdominal fat predominance in women is associated with a decreased prevalence of the high risk P2, DY mammographic breast patternsD Beijerinck, P A van Noord, J C Seidell, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-arm randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861)P F Bruning, J M Bonfrèr, J Wildiers, et al.
Breast Cancer Research and Treatment|January 1, 1984
Pros and cons of aminoglutethimide for advanced postmenopausal breast cancerP F Bruning, J G Bonfrèr, E Engelsman, et al.
British Journal of Cancer|February 1, 1990
Bone mineral density after adjuvant chemotherapy for premenopausal breast cancerP F Bruning, M J Pit, M de Jong-Bakker, et al.
International Journal of Cancer|April 15, 1987
Comparison of circulating MAM-6 and CEA levels and correlation with the estrogen receptor in patients with breast cancerJ Hilkens, J M Bonfrer, V Kroezen, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Neurology|July 13, 2000
Response of leptomeningeal metastases from breast cancer to hormonal therapyW Boogerd, L D Dorresteijn, J J van Der Sande, et al.
Cancer|March 26, 1999
Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinomaS B Schagen, F S van Dam, M J Muller, et al.
Journal of Chromatography|July 13, 1990
High-performance liquid chromatographic method for the analysis of 10-ethyl-10-deaza-aminopterin and metabolites in plasmaO van Tellingen, J H Beijnen, H R van der Woude, et al.
International Journal of Epidemiology|February 8, 2000
Body fat distribution and obesity in pre- and postmenopausal breast cancerE Sonnenschein, P Toniolo, M B Terry, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
Pamidronate infusions as single-agent therapy for bone metastases: a phase II trial in patients with breast cancerC T Tyrrell, P F Bruning, F May-Levin, et al.
International Journal of Obesity|January 1, 1991
Abdominal fat predominance in women is associated with a decreased prevalence of the high risk P2, DY mammographic breast patternsD Beijerinck, P A van Noord, J C Seidell, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-arm randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861)P F Bruning, J M Bonfrèr, J Wildiers, et al.
Breast Cancer Research and Treatment|January 1, 1984
Pros and cons of aminoglutethimide for advanced postmenopausal breast cancerP F Bruning, J G Bonfrèr, E Engelsman, et al.
British Journal of Cancer|February 1, 1990
Bone mineral density after adjuvant chemotherapy for premenopausal breast cancerP F Bruning, M J Pit, M de Jong-Bakker, et al.
International Journal of Cancer|April 15, 1987
Comparison of circulating MAM-6 and CEA levels and correlation with the estrogen receptor in patients with breast cancerJ Hilkens, J M Bonfrer, V Kroezen, et al.
Pageof 7